|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,340,000,000 |
Market
Cap: |
115.20(B) |
Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
52
Week Range: |
$76.84 - $94.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 164 |
Guru Rank Value : 8.6 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
22,287 |
22,287 |
97,812 |
Total Sell Value |
$0 |
$1,911,369 |
$1,911,369 |
$8,295,887 |
Total People Sold |
0 |
1 |
1 |
6 |
Total Sell Transactions |
0 |
2 |
2 |
11 |
End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Blomquist Denise L. |
Chief Accounting Officer |
|
2025-06-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
310 |
10,143 |
|
- |
|
Kiil Harry Skip |
EVP & President Cardiovascular |
|
2025-05-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,442 |
|
2% |
|
Walter Matthew R. |
SVP, Chief HR Officer |
|
2025-05-02 |
4 |
D |
$84.85 |
$2,885 |
D/D |
(34) |
26,054 |
|
- |
|
Craig Arnold |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
40,216 |
|
- |
|
Fonseca Lidia |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
5,675 |
|
- |
|
Nabel Elizabeth G |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
17,615 |
|
- |
|
Lewis Gregory P |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$15,313 |
D/D |
(181) |
3,785 |
|
- |
|
Powell Kendall J |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
48,622 |
|
- |
|
Goldsmith Andrea Jo |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
10,247 |
|
- |
|
Hogan Randall J |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
47,029 |
|
- |
|
Lofton Kevin E |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
8,171 |
|
- |
|
Donnelly Scott C |
Director |
|
2025-04-29 |
4 |
D |
$84.60 |
$18,274 |
D/D |
(216) |
21,630 |
|
- |
|
Craig Arnold |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
40,432 |
|
- |
|
Fonseca Lidia |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
5,891 |
|
- |
|
Blomquist Denise L. |
Chief Accounting Officer |
|
2025-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,975 |
10,453 |
|
- |
|
Nabel Elizabeth G |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
17,831 |
|
- |
|
Lewis Gregory P |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
3,966 |
|
- |
|
Powell Kendall J |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
48,838 |
|
- |
|
Goldsmith Andrea Jo |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
10,463 |
|
- |
|
Hogan Randall J |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
47,245 |
|
- |
|
Lofton Kevin E |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
8,387 |
|
- |
|
Donnelly Scott C |
Director |
|
2025-04-28 |
4 |
A |
$84.04 |
$175,055 |
D/D |
2,083 |
21,846 |
|
- |
|
Marinaro Michael |
EVP & President, Surgical OU |
|
2025-03-03 |
4 |
D |
$94.30 |
$54,223 |
D/D |
(575) |
40,675 |
|
- |
|
Pieton Thierry |
EVP & Chief Financial Officer |
|
2025-03-03 |
4 |
A |
$94.30 |
$2,900,102 |
D/D |
30,754 |
30,754 |
|
- |
|
Marinaro Michael |
EVP & President, Surgical OU |
|
2025-01-27 |
4 |
D |
$92.46 |
$191,670 |
D/D |
(2,073) |
41,250 |
|
- |
|
710 Records found
|
|
Page 1 of 29 |
|
|